Tomas Miranda Katz
About Tomas Miranda Katz
Tomas Miranda Katz is a Senior Research Associate at IGM Biosciences, Inc., with a background in biotechnology and extensive experience in purification techniques. He has previously held positions at several pharmaceutical companies, focusing on novel purification and formulation methods for antibody therapies.
Current Role at IGM Biosciences
Tomas Miranda Katz serves as a Senior Research Associate at IGM Biosciences, Inc. since 2022. In this role, he focuses on advancing research initiatives within the organization. His work contributes to the development of innovative biotechnological solutions, particularly in the area of antibody therapies.
Previous Experience at Sangamo Therapeutics
Tomas worked at Sangamo Therapeutics, Inc. in two capacities. He served as a Process Development Associate II for four months in 2020, followed by a role as Process Engineer II from 2020 to 2021 for eight months. His responsibilities involved process development and engineering, contributing to the company's therapeutic projects.
Background in Biotechnology at Vaxart Inc.
Tomas held multiple positions at Vaxart Inc., beginning as a Manufacturing Associate from 2017 to 2018 for three months. He then advanced to Manufacturing Associate II from 2018 to 2019 for one year, and later became a Senior Process Development Associate for three months in 2019. His roles focused on manufacturing processes and development within the biotechnology sector.
Educational Background in Molecular Biology
Tomas studied at Swarthmore College, where he earned degrees in Biology and History from 2012 to 2016. His education provided a strong foundation in molecular biology, which supports his current work in biotechnology and research.
Specialization in Purification Techniques
Tomas specializes in developing ultrafiltration and diafiltration (UFDF) processes for antibody therapies. He possesses extensive experience in cell culture and downstream purification processes, which are critical for the development of biopharmaceutical products.